Coloplast A/S (OTCMKTS:CLPBY) Upgraded to Hold by Zacks Investment Research

Zacks Investment Research upgraded shares of Coloplast A/S (OTCMKTS:CLPBY) from a sell rating to a hold rating in a research note released on Wednesday, March 7th.

According to Zacks, “Coloplast A/S develops and provides health care products and services. Its operating business segments consist of Chronic Care, Urology Care and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Urology Care segment offers urological products, including disposable products. The Wound and Skin Care segment covers the sale of wound and skin care products. Coloplast A/S is headquartered in Humlebaek, Denmark. “

Shares of Coloplast A/S (CLPBY) traded down $0.01 during midday trading on Wednesday, reaching $8.45. 36,251 shares of the company were exchanged, compared to its average volume of 148,741. Coloplast A/S has a fifty-two week low of $7.15 and a fifty-two week high of $9.01.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings results on Thursday, February 1st. The company reported $0.07 earnings per share for the quarter. The company had revenue of $625.80 million during the quarter. analysts expect that Coloplast A/S will post 0.31 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This article was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at

Coloplast A/S Company Profile

Coloplast A/S develops and markets intimate healthcare products and services worldwide. The company operates through three segments: Chronic Care, Urology Care, and Wound & Skin Care. It provides ostomy care products for intestinal dysfunction resulting from disease, accident, and congenital disorder.

Get a free copy of the Zacks research report on Coloplast A/S (CLPBY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with's FREE daily email newsletter.

Leave a Reply